Upload
Featured Recent Articles Topics Login Upload

Search Results for 'T2d-Hispanic'

T2d-Hispanic published presentations and documents on DocSlides.

Welcome to the 83 Scientific Sessions
Welcome to the 83 Scientific Sessions
by rosemary
RD. The Need for Separate Studies in People with T...
Page 2 of 13Salzanoetal Cardiovascular Diabetology 2022
Page 2 of 13Salzanoetal Cardiovascular Diabetology 2022
by nicole
Backgroundere is an intimate link between heart f...
All forms of diabetes have very serious effects on health In addition
All forms of diabetes have very serious effects on health In addition
by clara
Figure 1 T1D Incidence Rates Worldwide 0510152025...
Clinical Presentation of Type 2 Diabetes 1 Age ≥45 years Family history of T2D or cardiovascular disease
Clinical Presentation of Type 2 Diabetes 1 Age ≥45 years Family history of T2D or cardiovascular disease
by tatyana-admore
Clinical Presentation of Type 2 Diabetes 1 Age ...
Prediabetes Management 1
Prediabetes Management 1
by luanne-stotts
AACE Prediabetes Consensus Statement: Summary. Un...
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
by tatyana-admore
Expert Panelists. Program Goals. Evaluating CV Ri...
Tackling the epidemic of Non-communicable disease
Tackling the epidemic of Non-communicable disease
by danika-pritchard
Professor John Chambers . BA, MBBS, FRCP, PhD. Im...
Why Do We Treat Obesity?
Why Do We Treat Obesity?
by myesha-ticknor
Metabolic Complications. 2. Diabetes Risk. Metabo...
Prediabetes Management
Prediabetes Management
by giovanna-bartolotta
1. AACE Prediabetes Consensus Statement: Summary....
Think Healthy Please Practical Guide Diabetes Thanet
Think Healthy Please Practical Guide Diabetes Thanet
by briggs522
Real Food - Real Hope. changing. direction. Jeremy...
The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
by ishaan
John McMurray. BHF Cardiovascular Research Centre,...
Distribution of direct healthcare
Distribution of direct healthcare
by hailey
costs and obesity-related complications among high...
Setting up and Implementing SMAs in your practice
Setting up and Implementing SMAs in your practice
by oneill
Design your SMA thoughtfully. “... individual me...
ACSM Expert Consensus Statement
ACSM Expert Consensus Statement
by cady
on Exercise / Physical Activity for Individuals wi...
"I Don't Need Any of Those Damned
by elise
Pills” . New . Perspectives on Understanding and...
Dr. Marc Evans Latest clinical updates on DPP4is ;
Dr. Marc Evans Latest clinical updates on DPP4is ;
by amelia
Introduction to Linagliptin . SC-IR-00003. Disclo...
Outline 1000 Genomes Project (DA)
Outline 1000 Genomes Project (DA)
by faith
Update and rationale. Low-pass sequencing (Goncalo...
gDgDx000Eaix000Es tatinsfR tx000Fx000E Faculty f
gDgDx000Eaix000Es tatinsfR tx000Fx000E Faculty f
by mila-milly
k, HCntl3B i Ut iuiRg(l ,t...
Does your patient have T1 T2 or
Does your patient have T1 T2 or
by natalie
MODY? Aparna Pal Royal Berkshire Hospital Foundati...
Where’s the Beet: A Correlation Between a Vegan Diet & the Reduction in Type 2 Diabetes
Where’s the Beet: A Correlation Between a Vegan Diet & the Reduction in Type 2 Diabetes
by madeline
Rachel Lubitz. Ramapo College of New Jersey. What ...
Type 2 Diabetes With type 2 diabetes, your body either resists the effects of insulin — a hormone
Type 2 Diabetes With type 2 diabetes, your body either resists the effects of insulin — a hormone
by melanie
Type 2 Diabetes. High blood glucose. Insulin secre...
Diabetes and Bone Disease
Diabetes and Bone Disease
by priscilla
Omid . Gharooi. . Ahangar. 65-year-old . female w...
SurgeryforObesityandRelatedDiseases122016453ASMBSGuidelinesStatements
SurgeryforObesityandRelatedDiseases122016453ASMBSGuidelinesStatements
by wilson
AmericanSocietyforMetabolicandBariatricSurgeryposi...
EDUCATIONAL SLIDE MODULES
EDUCATIONAL SLIDE MODULES
by articlesnote
Module C: . Evidence for effects of older glucose-...
Obesity: More Than a Weight Problem
Obesity: More Than a Weight Problem
by pamella-moone
Obesity Introduction. Obesity Meets AMA Criteria ...
CVD in Diabetes Suvi Karuranga and Els Sung (IDF Executive Office)
CVD in Diabetes Suvi Karuranga and Els Sung (IDF Executive Office)
by alexa-scheidler
Stela Prgomelja (BCV member from Serbia). Decembe...
Combination Therapy for Type 2 Diabetes
Combination Therapy for Type 2 Diabetes
by lois-ondreau
Combination Therapy for Type 2 Diabetes Septembe...
ENDOCRINE PRACTICE Vol 21 No. 4 April 2015
ENDOCRINE PRACTICE Vol 21 No. 4 April 2015
by ellena-manuel
ENDOCRINE PRACTICE Vol 21 No. 4 April 2015 Ameri...
Management of Common Comorbidities in Diabetes
Management of Common Comorbidities in Diabetes
by celsa-spraggs
1. Obesity. Management of Common Comorbidities in...
Effective HbA 1c Reduction in T2D: Designing Appropriate Treatment Strategies
Effective HbA 1c Reduction in T2D: Designing Appropriate Treatment Strategies
by stefany-barnette
Goals. Recommended HbA. 1c. targets. Important R...
How Do We Treat Obesity?
How Do We Treat Obesity?
by karlyn-bohler
Weight Loss Medications. 2. 3. Phentermine. 4. DE...
Updates Abound Introduction
Updates Abound Introduction
by sherrill-nordquist
GLP-1 RAs in Combination With Basal Insulin Appro...
Special Consideration in Insulin Therapy
Special Consideration in Insulin Therapy
by stefany-barnette
Epidemiology and Pathogenesis of Diabetes . in Ol...
Early and Intensive T2D Management:
Early and Intensive T2D Management:
by ellena-manuel
Program Goals. TECOS. Sitagliptin in Patients Wit...
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
by giovanna-bartolotta
Program Goals. Complementary Mechanism of Action ...
Glycemic Management of Type 2 Diabetes
Glycemic Management of Type 2 Diabetes
by faustina-dinatale
1. AACE Comprehensive Care Plan. Handelsman YH, e...
Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?
Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?
by danika-pritchard
2013 ACC/AHA Cholesterol Guidelines. Statin Initi...
GLP-1 Agonist Clinical Case Challenge: Intensifying Therapy and Improving Management of T2D
GLP-1 Agonist Clinical Case Challenge: Intensifying Therapy and Improving Management of T2D
by stefany-barnette
Program Goal. Case Presentation: Diane. Case Pres...
SGLT2 Inhibitors and Their Clinical Impact:
SGLT2 Inhibitors and Their Clinical Impact:
by aaron
Ominous Octet. Renal Handling of Glucose. Active ...
ENDOCRINE PRACTICE Vol 21
ENDOCRINE PRACTICE Vol 21
by min-jolicoeur
No. . 4 April 2015 . American Association of Clin...